Man Group PLC Olema Pharmaceuticals, Inc. Transaction History

Man Group PLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$2.55 - $4.97 $91,338 - $178,020	35,819 New	35,819 $124,000
Q4 2021 Feb 14, 2022	SELL	$8.75 - $30.71 $126,875 - $445,295	-14,500 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$22.96 - $30.13 $332,920 - $436,885	14,500 New	14,500 $400,000

145

58.3M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $248M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.